Viz.ai and Cortechs.ai partner to integrate quantitative MS neuroimaging into Viz Connect platform

Viz.ai and Cortechs.ai are integrating Cortechs' quantitative multiple sclerosis neuroimaging tools into the Viz Connect platform, aiming to streamline MS lesion quantification and reporting within the existing Viz workflow.

• Cortechs.ai's NeuroQuant MS software automatically quantifies brain lesions and brain atrophy metrics relevant to multiple sclerosis.
• The integration will allow Viz.ai users to access Cortechs' AI-powered MS analysis directly from the Viz Connect platform, potentially reducing the need for separate software.
• No clinical performance data or planned validation studies were included in this partnership announcement.

RadPigeon summaries are original and for information only. They are not clinical advice.